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ABSTRACT: The mannitol-specific transport protein in Escherichia coli, EIImtl, consists of three structural 
and functional domains: a hydrophilic EIII-like domain (the A domain); a hydrophobic transmembrane 
domain (the C domain); and a second hydrophilic domain (the B domain) which connects the A and C 
domains together. The A domain contains the first phosphorylation site, His554, while the B domain 
contains the second phosphorylation site, Cys384. The phosphoryl group which is needed for the active 
transport of mannitol is sequentially transferred from P-enolpyruvate via the two phosphorylation sites to 
mannitol bound to the substrate binding site. In this paper, the expression, purification, and initial 
characterization of the B domain, IIBmtl, are described. Oligonucleotide-directed mutagenesis was used 
to produce an amber stop codon (TAG) and Hind111 restriction site in a flexible loop between the B and 
A domains in the subcloned gene fragment coding for IIBAmtl (van Weeghel et al., 1991~) .  The gene 
fragment coding for IIBmtl was then subcloned behind strong promoters, located in two different expression/ 
mutagenesis vectors, which directed the expression of the 15.3-kDa polypeptide in Escherichia coli. The 
domain was purified from E .  coli crude cell extracts by using Q-Sepharose Fast Flow, S-Sepharose Fast 
Flow, and hydroxylapatite column steps. This purification procedure resulted in 1 mg of pure IIBmtl/g of 
cell, wet weight. The purified B domain was analyzed in vitro for its catalytic activity with membranes 
containing the phosphorylation site mutant form of EIImtl, C384S, and with the transmembrane domain, 
IICmtl. The B domain, together with purified IIA, was able to restore the P-enolpyruvate-dependent 
phosphorylation activity of the membrane-bound C domain. Steady-state mannitol phosphorylation kinetics 
a t  saturating EI, HPr, and IIAmtl yielded an apparent K, of P-IIBmtl for IIC"' of 200 p M  and an apparent 
V,,, of 71 nmol of mtl-P min-' mg of membrane protein)-'. This V,,, value is comparable to that of 
wild-type EIImtl measured under the same experimental conditions. 
The uptake and phosphorylation of the carbohydrate 
substrate mannitol in Escherichia coli are catalyzed by the 
mannitol-specific transport protein enzyme I1 (EIImtl)l of the 
phosphoenolpyruvate-dependent phosphotransferase system 
(PTS)' [for reviews, see Postma and Lengeler (1985), Meadow 
et al. (1990), and Lolkema and Robillard (1992)l. The 
mannitol transport protein is localized in the cytoplasmic 
membrane. The cytoplasmic portion of the enzyme possesses 
two active-site residues, His554 and Cys384, which become 
phosphorylated during turnover (Pas et al., 1988; Pas & 
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Robillard, 1988a,b). Sequence comparisons of several sugar 
transport proteins (Saier et al., 1988; Ebner & Lengeler, 1988) 
and extensive biochemical, genetic engineering, and kinetic 
studies have revealed that EIImtl, like many of the other enzyme 
11's or enzyme 111111 pairs of the PTS, consists of three 
structural and functional domains. There is a hydrophilic 
enzyme III-like domain, IIAm", containing the essential His554 
as the first phosphorylation site, a second hydrophilic domain, 
IIB"', which contains the Cys384 as the second phosphory- 
lation site, and a hydrophobic transmembrane domain, IICmtl, 
which is able to bind and transport the mannitol (Grisafi et 
al., 1989; Stephan & Jacobson, 1986; Stephan et al., 1989; 
White & Jacobson, 1990; van Weeghel et al., 1991a,b,c; 
Lolkema et al., l990,1991a,b). Thephosphoryl groupderived 
from P-enolpyruvate is transferred via enzyme I and HPr to 
His554 on the A domain, which in turn phosphorylates Cys384 
located on the B domain. This latter active-site residue is 
involved in the phosphorylation of mannitol bound to its binding 
site on the C domain. Recent kinetic studies have established 
that the transmembrane C domain constitutes the mannitol 
translocator. Dephosphorylated EIImtl and the subcloned 
IICmtl are able, under certain circumstance, to catalyze a slow 
facilitated diffusion of mannitol (Lolkema et al., 1990). 
Furthermore, evidence has been accumulating that, in terms 
of the catalytic mechanism, the translocation and phospho- 
rylation activities are separable functions localized on different 
domains. Lolkema et al. (1991a,b) have demonstrated that 
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phosphorylation of the enzyme modulates the activity of the 
translocator domain; phosphorylation of Cys384 causes at 
least a 1000-fold stimulation of the translocation rate by a 
conformational coupling between the B and C domains. 
Studies of the structures and activities of the individual domains 
should, therefore, provide important insights into how the 
individual domains modulate the transport and phosphory- 
lation activities. 
In order to carry out such structure-function studies, several 
different expression-coupled mutagenesis phagemid systems 
wereconstructed (van Weeghelet al., l990,1991a,b,c).These 
expression vectors enabled us to make site-directed mutations 
for easy subcloning of gene fragments coding for different 
EIImtl domains, IIA"', IIBAmtl, and IICmtl, to overexpress 
these domains, and to produce several important phospho- 
rylation site mutants which were used in kinetic studies (van 
Weeghel et al., 1991a; Lolkema et al., 1991b) and in 
complementation assays with expressed domains (van Weeghel 
et al., 1991b,c). This report describes the mutagenesis, 
overexpression, and purification of IIBmtl, together with kinetic 
evidence that this domain is enzymatically active. 
MATERIALS AND METHODS 
Materials. Restriction endonucleases, DNA polymerase 
Klenow fragment, T4 DNA ligase, and T4 polynucleotide 
kinase were obtained from Boehringer Mannheim. M13K07 
helper phage was purchased from Pharmacia. Q-Sepharose 
Fast Flow and S-Sepharose Fast Flow were from Pharmacia, 
and hydroxylapatite was from Bio-Rad. Nitrocellulose filters 
were from Schleicher & Schuell. The four synthetic oligo- 
nucleotides (Rl ,  R7, R19 amber, and R23 obtained from 
Eurosequence BV Groningen) were prepared on an Applied 
Biosystems Model 380B DNA synthesizer, completely depro- 
tected, and used unpurified. Enzyme I and HPr were purified 
asdescribed (Dooijewaard et al., 1979; Van Dijket al., 1990). 
~-[l- '~C]Mannitol  (59 mCi/mmol; 1 mCi = 37 MBq) was 
purchased from the Radiochemical Centre Amersham. The 
nonionic detergent decyl-PEG was obtained from B. Kwant 
(Department of Chemistry, University of Groningen). IgG- 
horseradish peroxidase conjugate and reagents for color 
development were purchased from Bio-Rad. Phenylmethane- 
sulfonyl fluoride (PMSF) was obtained from Serva. Other 
biochemicals were of analytical grade. 
Bacterial Strains, Plasmids, and Growth Conditions. E. 
coli strains ASL-1 [F-, lacY1, galT6, xyl-7, thi-1, hisG1, 
argG6, metB1, rpsL104, mtlA2, gutA50, gatA5O (MAL+) 
recA], LJ1008-11-3 [C600; F-, lacy, galT6, xyl-7, thi-1, 
hisG1, argG6,metB1, rpsL104, mtlA2,gutA5O,gatA5O,recA, 
(Mal+)] (Van Weeghel et al., 1990), and JMlOl [A(lac- 
proAB), thi; F',traD36,proAB, lacIqZAM 151 (Yanish-Perron 
et al., 1985) were used for plasmid propagation and as host 
strains for protein expression. E. coli strains BMH 71-18 
MutL, [A(lac-proAB), thi, supE; F' lacIqZAM1 5,proA+B+] 
(Carter et al., 1985) and HB2154 [A(lac-proAB), thi, 
ara, phx, mutL::TnlO (Tc, 10 Mg/mL); F', proA+B+, 
lacIqZ-AM15J (Kramer et al., 1984) were both used for 
oligonucleotide-directed mutagenesis. E. coli BW3 13 [dut, 
ung, relA, spoT1, F'lysA] was used to produce uracil- 
containing single-stranded DNA for the Kunkel mutagenesis. 
Phagemid pMcCIIIi was obtained as described (van Weeghel 
et al., 1991c) and used as the parental vector in the Kunkel 
mutagenesis procedure (Kunkel, 1985). The expression 
phagemid pMcCl was obtained as described (van Weeghel et 
al., 1991 b). Strains harboring different plasmids or phagemids 
were grown in 2 X TY broth (16 g of Bacto-tryptone, 10 g 
Robillard et al. 
of yeast extract, and 5 g of NaCl in 1 L) supplemented with 
the appropriate antibiotics. McConkey indicator plates (agar 
base, Difco) containing 1% D-mannitol were prepared as 
indicated by the supplier. 
Site-Directed Mutagenesis and Plasmid Constructions. 
Standard recombinant DNA techniques were performed 
according toSambrooket al. (1989). Oligonucleotide-directed 
mutagenesis using single-stranded pMcCIIIi and pMcCII 
DNA was done according to the Kunkel mutagenesis protocol, 
by using single-stranded uracil-containing DNA (Kunkel, 
1985). The mismatch oligomer Rlgamber, 5'-GAACAG- 
GTTAAGCTTGGACT&GTCAAAGCT-3', was construct- 
ed to introduce an amber stop codon and a new HindIII 
restriction site invector pMcCIIIi. Plasmid pMcCIIIi, which 
directed the overexpression of the complete IIBA"', was used 
as the starting plasmid for vector constructions (van Weeghel 
et al., 199 IC). This particular expression vector contained 
the B domain in a translational fusion behind the strong X PR 
promoter (Davison et al., 1987). Plasmid DNA was prepared 
from 18 colonies and digested with HindIII restriction enzyme. 
The mutant plasmid pMcCIIIam, containing the new HindIII 
site, gave two fragments of approximately 700 bp upon 
restriction analysis. The parental vector pMcCIIIi showed 
only the expected 1.4-kb fragment (Figure 1). Subcloning of 
the HindIII fragment containing IIBmfl, fused to the ribosomal 
binding site (RBS) and ATG start codon of the cro gene 
downstream of the PR promoter, was done into the parental 
phagemid pMc5-8 (Stanssens et al., 1989) to delete the A 
domain. The HindIII fragments were excised from vector 
pMcCIIIam using HindIII restriction enzyme, gel-purified, 
and ligated into the vector pMc5-8 linearized with the same 
enzymes. The ligation mixture was transformed into JMlOl 
and plated on 2 X TY plates containing chloramphenicol (25 
pg/mL). The orientation of the correct insert in the recom- 
binant plasmid pMcCII was identified by digesting isolated 
plasmid DNA with HindIII and SnaBI (Figure 1). Vector 
pMcCII was subsequently transformed into different E. coli 
strains, ASL-1, LJ1008-11-3, and JM101, to test the con- 
stitutive expression of the B domain from the strong PR 
promoter. Due to this HindIII cloning procedure, part of the 
thermolabile cI857 gene in pMcCII was deleted, which would 
result in constitutive expression of IIBmtl from the unrepressed 
promoter. In order to test IIB"' expression from another 
strong promoter, DNA coding for the B domain was cloned 
downstream of the Ptrc promoter situated in pMcCI (Figure 
1). This promoter was used before tooverexpress the A domain 
to very high levels in Escherichia coli (van Weeghel et al., 
199 1 b). 
Plasmid pMcCII was also used to transform E. coli BW3 13 
in order to produce and isolate uracil-containing single- 
stranded DNA (ss-UDNA). In combination with the mu- 
tagenic oligomer R23, 5'-GAGGATCCATEAACCT- 
CC-3', the ss-UDNA was used to generate a unique NcoI site 
around the ATG initiation codon of IIB"' (Figure 2). The 
ligation mixture was transformed into competent E. coli cells 
after the site-directed mutagenesis reaction had been com- 
pleted. After selection on 2 X TY plates containing chloram- 
phenicol, plasmid DNA was prepared from randomly picked 
colonies and tested for the presence of a unique NcoI restriction 
site. A new NcoI was generated by changing nucleotides -1 
(T - C) and -2 (G - C) upstream of the ATG codon (Figure 
2D). The resulting plasmid, pMcCIINcolcontaining the NcoI 
mutation, was digested with the restriction enzymes NcoI and 
HindIII, The excised gene fragment encoding IIBmtl was gel- 
purified and ligated into pMcCI DNA that had been linearized 
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FIGURE 1: Construction of IIBmfl expression vectors. (1) Site-directed mutagenesis was used in combination with primer R19am to introduce 
an amber stop codon (TAG) and a HindIII site in pMcCIIIi, the parental plasmid for expression of the IIBAmfl domain. The resulting vector, 
pMcCIIIam, was used to construct the vector pMcCII for IIBmtl. (2) Single-stranded pMcCII and R23 were used to create a unique NcoI 
site with an internal ATG initiation codon. (3) The mutant vector was named pMcCIINco1 and digested with the restriction enzymes NcoI 
and HindIII. The excised DNA fragment was used to construct a fusion between the IIBmtl domain-encoding region and the strong Ptrc promoter 
in pMcCI, which resulted in the recombinant expression plasmid pMcCIIPtlc. 
with the same restriction enzymes. The resulting recombinant fusion with the lac RBS and ATG start codon just behind the 
vector, pMcCIIPtrc, now contained IIBmtl as a translational PR promoter. The expression/mutagenesis vectors pMcCIIPt, 
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FIGURE 2: Schematic domain organization of EIImtl. (A) Organization of structural and functional domains along the EIImd polypeptide chain 
connected by hingeregions. The two sites of phosphorylation are indicated by His554 on IIAmtl and Cys384 on IIBmtl. (B) Calculated molecular 
weights (X lC3) of the different domains. (C) The flexible hinge region downstream of IIBmu was used to create an amber stop codon (TAG) 
and a Hind111 site. (D) Translational in-frame fusion of the IIBmtl DNA sequence with the PR promoter in vector pMcCII, and with the PUc 
in vector pMcCIIP-. 
and pMcCII were both used to obtain high levels of expression 
of IIB"' in E. coli. The actual efficiency of mutagenesis 
obtained with the Kunkel method was 50%. 
The entire gene encoding the B domain in pMcCII was 
sequenced by the dideoxynucleotide sequencing method 
(Sanger et al., 1977) using synthetic primers complementary 
to appropriate regions along the gene. The sequence was 
identical to that of Lee and Saier (1983) for the same portion 
of the gene. 
I S 0  Membrane Vesicles. IS0 vesicles were prepared from 
E. coli cells (ASL-1 and LJ1008-11-3) expressing the two 
EIIm" phosphorylation site mutants ( EIIm"-C384S and EIIm"- 
H554A) or the transmembrane C domain as described (van 
Weeghel et al., 1991a,c). The cells were pelleted by cen- 
trifugation, resuspended in buffer (25 mM Tris-HC1, pH 7.6, 
and 1 mM DTT at 4 "C), and lysed by passage through a 
French pressure cell at 10 000 psi. The membrane fraction 
was prepared as previously described (van Weeghel et al., 
1990). Aliquots of 5Cb100 pL were stored at -80 OC. 
Protein Concentration. Protein concentrations of the 
purified IIBmt' or pooled peak fractions after column chro- 
matography were determined by the method of Bradford 
(1976) using BSA as a standard. The protein concentration, 
in terms of the number of phosphorylatable active sites, was 
determined by the pyruvate-burst method (Robillard & 
Blaauw, 1987). The concentration of EII-C384S (0.68 pM), 
EII-H554A (2.8 pM), and IICmt' (3 pM) in the I S 0  vesicles 
was determined from mannitol binding data measured with 
flow dialysis as previously described (Lolkema et al., 1990). 
Purification of EIPt'-C384S. IS0 vesicles of E. coli ASL- 1 
expressing EIImt1-C384S were resuspended after ultracen- 
trifugation in 25 mM Tris-HC1, pH 8.4, 5 mM DTT, and 1 
mM NaN3 to a concentration of 1 mL/g of starting cells. The 
vesicles solution was added dropwise to an extraction buffer 
at 25 OC consisting of 20 mM Tris-HC1, pH 8.4, 50 mM 
NaCl, 1 mM NaN3,0.5% deoxycholate, and 1 mM PMSF. 
A ratio of 1 mL of vesicle solution per 19 mL of extraction 
buffer was used. The solution was gently stirred at 25 OC for 
30 min and centrifuged at  15OOOOg for 45 min. 
(A) Hexylagarose Chromatography. The supernatant was 
loaded at a rate of 1-2 mL/min onto a hexylagarose column 
(20 X 2.5 cm) equilibrated with extraction buffer lacking 
PMSF and washed with the same buffer until the OD280 was 
equal to that of the washing buffer. The column was eluted 
with a linearly decreasing gradient in DOC which was, at the 
same time, a linearly increasing gradient in dPEG. This was 
achieved by starting with 200 mL of 20 mM Tris-HC1, pH 
8.4, 1 mM DTT, 1 mM NaN3, and 50 mM NaCl containing 
0.25% DOC and gradually diluting it with 200 mL of the 
same buffer solution containing 2% dPEG instead of DOC. 
EIImt'-C384S was detected by a complementation assay for 
mannitol phosphorylation with membrane vesicles containing 
EIImt1-H554A (van Weeghel et al., 1991a) as follows. Assay 
mixtures (90 pL) containing 25 mM Tris-HC1, pH 7.6,5 mM 
MgC12, 5 mM DTT, 0.35% dPEG, HPr, EI, EIImt'-H554A 
vesicles, and aliquots of the hexylagarose fractions were 
incubated for 5 min at 30 OC. Then 10 pL of 330 pM [14C]- 
mtl was added and the incubation continued for 10 min at the 
same temperature. The reaction mixture was then loaded 
onto Dowex columns, and the [I4C]mtl-P was eluted and 
counted as described (Robillard & Blaauw, 1987). 
(B)  QSepharose Chromatography. The active fractions 
eluting from the hexylagarose column at approximately 1% 
dPEG were pooled and loaded directly onto a Q-Sepharose 
column (1.5 X 20 cm) equilibrated in 20 mM Tris-HC1, pH 
8.4,l mM DTT, 1 mM NaN3, and 0.25% dPEG. The column 
was washed with the same buffer, at pH 8, containing 150 
mM NaCl until the OD280 was reduced to background and 
then eluted with a linear gradient of 150-400 mM NaCl in 
the same buffer. The EIImt'-C384S activity was detected as 
above, and the active fractions were pooled and frozen until 
use. 
Expression and Purification of the IIBmtl Domain. The 
expression levels were analyzed in three different strains of 
E. coli harboring the vector pMcCII or pMcCIIPtrc: ASL- 1, 
LJ1008-11-3,and JM101. Thecellswereculturedin2 XTY 
broth. The expression of IIBmtl directed from pMcCII was 
constitutive because the cI repressor is lacking in all these 
strains. The expression from plasmid pMcCIIPt, was also 
constitutivein ASL-1 andLJ1008-11-3, but had tobeinduced 
with 1 mM IPTG in JM101, because of the presence of l a d ,  
repressor. 
LJ1008-11-3/pMcCII was used for theproductionof IIB"' 
because use of the plasmid PMcPtrcCII in LJ1008-11-3 or in 
JM101, with induction, did not result in higher levels of 
expression (see Results), A 50-mL overnight culture was used 
to inoculate 1 L of 2 X TY medium in the presence of 
chloramphenicol (25 pg/mL). The cells were grown for 16 
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h at 37 OC, after which they were harvested at 20000g (10 
min) at 4 OC. Under these culture conditions, 5 g of cells (wet 
weight) per liter of medium was routinely obtained. The cell 
pellets were resuspended in buffer (20 mM Tris-HC1, pH 9.5, 
1 mM EDTA, 1 mM PMSF, and 1 mM DTT) at 10 mL/g 
wet weight of cells and lysed by passing through a French 
pressure cell at 10 000 psi. After centrifugation of the 
suspension at 150000g for 60 min, the pellets containing cell 
debris and membrane fragments were discarded, and the 
supernatant was tested for IIBmtl activity in a complementation 
assay with EIImt1-C384S (see Materials and Methods) or 
analyzed by SDS-PAGE for expression. 
The first purification step involved a Q-Sepharose column 
(7 X 2.5 cm) equilibrated with buffer A (20 mM Tris-HC1, 
pH 9.5, and 1 mM DTT). Freshly prepared DTT was used 
during all purification steps. The IIBmtl-containing super- 
natant was applied to the column at a flow rate of 60 mL/h. 
The column was washed with the same buffer until the 280- 
nm absorbance of the effluent reached the base line. Elution 
was achieved with a linear gradient of 0-300 mM NaCl in 
buffer A at a flow rate of 30 mL/h. The total volume of the 
elutiongradient was 300 mL. Fractions were tested for activity 
and analyzed by SDS-polyacrylamide gel electrophoresis using 
Coomassie Blue staining. Fractions containing IIBmtl were 
pooled and dialyzed overnight against buffer B (20 mM KPi, 
pH 6.0, and 1 mM DTT) and loaded, at a rate of 60 mL/h, 
onto an S-Sepharose column (6 X 2.3 cm) which was 
equilibrated with buffer B. The column was washed with 3-4 
column volumes of buffer B. Finally, IIBmtl was eluted with 
a linear gradient of 0-500 mM NaCl in buffer B at a flow 
rate of 60 mL/h. The total volume of the gradient was 300 
mL. Fractions of 8 mL were collected and analyzed by SDS- 
PAGE for purity. Those fractions containing IIBmtl were 
pooled, dialyzed overnight against buffer C (10 mM KPi, pH 
7.0, and 1 mM DTT), and applied to the hydroxylapatite 
column (8 X 1 cm, 30 mL/h) equilibrated with the same 
buffer C. After the column was washed with 4-5 column 
volumes of buffer, elution was started using a gradient of 
10-100 mM KPi at a flow rate of 30 mL/h (80 mL). SDS- 
gel electrophoresis of the fractions was used toverify the IIBmtl 
elution profile. Those fractions containing IIBmtl were pooled 
and concentrated by pressure dialysis (Amicon, UM- 10 
membrane) and Centricon filtration (cutoff Mr 10 000). 
Protein Characterization. Analytical SDSpol yacrylamide 
gel electrophoresis (SDS-PAGE) of total cell extracts or 
column fractions was performed on 15% gels according to 
Laemmli (1970). Protein bands either were stained with 
Coomassie Blue or were electroblotted onto nitrocellulose 
filters (Towbin et al., 1979). The filters were used for 
immunodetection of IIBmtl with rabbit polyclonal antibodies 
elicited against native EIImtl as described (Pas et al., 1987). 
Isoelectrofocusing (IEF), to test the purity and homogeneity 
of the IIBmtl domain, was done on a Pharmacia Phast system 
with silver staining. The N-terminal amino acid sequence 
was determined with an Applied Biosystems Model 477A 
protein sequencer (pulse-liquid sequenator), connected on- 
line with a 120A PTH analyzer (Hewick et al., 1981). The 
amino acid composition was determined using an HP Ami- 
noquant with an automatic two-step precolumn derivatization 
with OPA and FMOC (Schuster, 1988). Hydrolysis was 
performed in the gas phase in 5.7 N HCl at 166 OC for 2 h. 
Complementation Assays for IIB. Assays were carried out 
as previously described by van Weeghel et al. (1991b). The 
assay mixtures routinely contained 25 mM Tris-HCl, pH 7.6, 
5 mM MgC12, 5 mM DTT, 0.35% decyl-PEG, 3.6 pm HPr, 
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FIGURE 3: Expression of IIBmt*. Coomassie-stained SDS-PAGE 
analysis of total cell extracts of E. coli LJ 1008- 1 1-3 cells harboring 
the IIBmtl expression plasmid pMcCII in lanes A and B and without 
the plasmid in lane C. Lane D, positions of molecular mass standards 
given in kilodaltons. The arrow at 16.0 kDa indicates expressed 
IIBmtl. Lanes A and B were scanned to determine the intensity of 
the 16-kDa band relative to the total protein. This was done by 
digitizing the photo of the gel using a CDC camera and determining 
the intensities with IMAGIC, software for electron micrograph image 
processing. Processing involved averaging 10 tracks taken in the 
lengthwise direction across lane A and then integrating. The same 
was done for lane B. The intensity of the 16-kDa band in lanes A 
and B was approximately 7% of the total integrated intensity over 
the whole gel. 
0.22 pM EI, 20-33 pM [ 14C]mannitol, and inside-out (ISO) 
vesicles containing EIImt1-C384S or IICmtl. Crudecell extracts 
and column fractions containing IIBmtl were assayed for their 
ability to restore the activity of membrane vesicles containing 
the EIImt1-C384S mutant. Reactions were started by the 
addition of 5 mM P-enolpyruvate. [ 14C]Mannitol phosphate 
production was measured according to the procedure of 
Robillard and Blaauw (1987). The details of specific 
experiments are provided in the text and figure legends. 
31P NMR Measurements. IIBmtl was phosphorylated in 
situ in the NMR tube using a buffer containing 25 mM Tris- 
HCl, pH 8.3, 5 mM MgC12, 5 mM DTT, 20 mM P- 
enolpyruvate, 4 pM EI, 5 pM HPr, and 10 pM IIA. The 
measurements were performed with a VARIAN VXR300 
NMR spectrometer operating at 121.4 MHz using a 5-mm 
bore probe. The spectra were recorded at 25 OC with a 5000- 
Hz sweep width, a 17-ps 90' flip angle, and a repetition time 
of 5 s. 
RESULTS 
Construction of Expression Vectors. Figure 1 shows the 
construction of the IIBmtl expression vectors. The gene 
fragment coding for the B domain could be generated from 
plasmid pMcCIIIi by site-directed mutagenesis using an 
oligonucleotide that introduced an amber stop codon at  position 
Asp488 (GAT - TAG) of the amino acid sequence and a 
Hind111 restriction site at position 1605 of the mtlA DNA 
sequence. Asp488 is located in a proposed flexible loop 
which connects the A domain with the B domain as shown in 
Figure 2. 
The expression vectors pMcCII and PMcCIIPt, were 
transformed into various E. coli strains to test the expression 
of the B domain. Figure 3 shows that efficient and stable 
expression of IIBmtl was achieved in LJ1008-11-3 cells. A 
16-kDa protein band accounting for approximately 7% of the 
total intensity is clearly visible in cells harboring the recom- 
binant phagemid pMcCII, as shown in duplicate in lanes A 
and B. A control preparation of LJ1008-11-3 without the 
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LJ1008-11-3" 414 1 .o 100 
Q-Sepharose 15 15.3 55 
S-Sepharose 5.7 24.3 33.5 
hydroxylapatite 5.4 23.5 30.7 
10 20 30 40 
Fraction n. 
FIGURE 4: Elution and activity profile of IIBmtl from Q-Sepharose. 
(A) Coomassie Blue stained 15% polyacrylamide gel of Q-Sepharose 
column fractions (10, 14,20,22,24,26,28, 30, and 32) containing 
IIBmtl eluted during a linear NaCl gradient. The position of IIBmtl 
is indicated by an arrow. (B) Activity profile of different column 
fractions, some of which correspond to the fractions shown in panel 
A. The activities were measured in a complementation assay with 
inside-out vesicles containing the EII-C384S mutant. Assay mixtures 
containing 25 mM Tris-HC1, pH 7.6, 5 mM MgC12, 5 mM DTT, 
0.35% decyl-PEG, 3.6 pM HPr, 0.22 pM EI, 34.4 nM EII-C384S, 
and aliquots of the Q-Sepharose fractions were incubated for 5 min 
at 30 OC. Then 10 pL of 330 pM [I4C]mtl was added, and the 
incubation was continued for 10 min at the same temperature. The 
reaction mixtures were then loaded onto Dowex columns, and the 
[14C]mtl-P was eluted and counted as described (Robillard & Blaauw, 
1987). 
B 
Crude cell extract after removal of the cell debris and membranes 
of LJ1008-11-3. Proteinconcentrations weredetermined by the method 
of Bradford as described. The activity was determined using the EII- 
C384S mutant complementation assay described under Materials and 
Methods. Assay mixtures contained 25 mM Tris-HC1, pH 7.6, 5 mM 
MgC12, 5 mM DTT, 0.35% decyl-PEG, 3.6 pM HPr, 0.22 pM EI, and 
inside-out (ISO) vesicles containing 34.4 nM EIIX384S. Aliquots 
containing IIBmtl were added and incubated for 5 min at 30 "C, and the 
phosphorylation reaction was started by addition of 30 pM [ I4C]mannitol. 
Samples were taken at various times and analyzed for mtl-P to determine 
the phosphorylation rates (Robillard & Blaauw, 1987). 
plasmid did not show any IIBmtl expression (Figure 3, lane C). 
The highly expressed protein of 26 000 daltons is most likely 
the chloramphenicol acetyltransferase (CAT) which confers 
resistance to chloramphenicol. Expression of IIBmtl from 
plasmid pMcCII in E. coli ASL-1 did not result in an improved 
expression level. The IPTG-inducible expression system 
pMcCIIPtrc also did not lead to higher levels of IIBmtl relative 
to constitutive expression. Expression of IIBmtl was completely 
lost when the whole expression cassette encoding IIBmtl was 
subcloned in the wrong orientation in pMc5-8, without the 
essential transcription terminators, fdTl and fdT2, to produce 
the correct mRNA transcripts. 
Purification of IIB"'. Five grams, wet weight, of cell 
material from a 1-L cultureof LJ11008-11-3/pMcCII grown 
for 16 h was used for the purification of IIBmtl. It was found 
that freshly prepared DTT was necessary to keep the protein 
active. Insufficient DTT led to complete and irreversible 
inactivation, most likely due to oxidation of the active-site 
Cys384. This sensitivity to inactivation is higher for IIBmtl 
than for intact, purified EIImtl. The Q-Sepharose column 
was used at pH 9.5 because we had observed, during the 
purification of IIAmtl, that the CAT protein was strongly bound 
to the resin at this pH and did not elute during the NaCl 
gradient. The B domain eluted with 156200 mM NaCl. The 
activity profile determined using the EIImt1-C384S comple- 
mentation assay is presented in Figure 4 along with the SDS- 
gel electrophoresis pattern of selected fractions. Fractions 
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FIGURE 5: Coomassie Blue stained 15% SDS-polyacrylamide gels 
of IIBmtl at various stages of purification. (A) Lane A, crude cell 
extracts after high-speed centrifugation to remove cell debris and 
membrane fragments; lane B, pooled peak fractions from Q-Sepharose 
column chromatography; lane C, pooled peak fraction from S- 
Sepharose column chromatography; lane D, pooled fractions from 
hydroxylapatite column chromatography; lane E, molecular mass 
markers (in kilodaltons); the position of IIBmtl (16.0 kDa) is indicated 
by an arrow; lane F, immunochemical detection of purified IIBmtl 
with polyclonal antibodies raised against native EIImtl. (B) Various 
concentrations of purified IIBmtl. Lane 1, molecular mass markers. 
Lanes 2-5, 45, 118, 39, and 17 pg of purified IIBmtl, respectively. 
containing IIBmtl were pooled. Table I shows that 55% of the 
starting activity was recovered in the pool. The purity was 
judged to be 7680% as shown in Figure 5A, lane B. 
The PI of the B domain was determined by isoelectric 
focusing to be approximately 6.3. The protein bound to 
S-Sepharose at a pH of 6.0 and eluted at a NaCl concentration 
of 250 mM. Two minor protein bands with molecular weights 
of 21 000 and 32 000 could not be removed during this step. 
The recovery of active IIBmtl was 60% of the IIBmtl present 
in the Q-Sepharose pool or 30% of the IIBmtl in the starting 
material (Table I). The purity was estimated to be 90% on 
the basis of SDS-PAGE analysis of the S-Sepharose pool 
(Figure 5A, lane C). 
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a On the basis of an expected molecular mass for IIBmu of approximately 
16 kDa. Cysteine was not determined. 
5.20 
FIGURE 6: Silver-stained isoelectric focusing gel of purified IIB"'. 
Protein for this gel was taken from the same stock as that used for 
the gel in Figure 5B. The isoelectric focusing was done on a Pharmacia 
Phast system using gels in the pH range 5-8. The gel was silver- 
stained. Lane A (left), pH markers; the p l  of each marker is given 
at the left side of the figure. Lane B (middle), 0.4 mg/mL IIBmt*; 
lane C (right), 0.15 mg/mL IIB"'. 
The hydroxylapatite column was necessary to eliminate 
the two remaining contaminants present in the S-Sepharose 
pool (Figure 5A, lane D). The recovery of IIBmtl from this 
purification step was 92%. The B domain reacted with 
polyclonal antibodies raised against native EIImtl (Figure 5A, 
lane F). Polyclonal antibodies raised against purified IIBmtl 
reacted on immunoblots with intact EIImtl, IIBmtl, and IIBAmtl, 
but not with IIAmtl. 
The purity of IIBmtl was estimated to be more than 99% 
from the Coomassie blue stained SDS-polyacrylamide gel in 
Figure 5B in which the protein concentration was varied over 
a 1 0-fold range. The total purification procedure resulted in 
1 mg of IIBmtl/g of wet weight cells. The final recovery was 
3096, and the final purification factor was 23.5 (see Table I). 
This purification factor implies that IIBmtl constitutes 6 5 %  
of the total protein in crude cell extract. Densitometric analysis 
of lanes A and B of the gel in Figure 3 shows that the integrated 
intensity of the band at 16 kDa is approximately 7% of the 
total protein intensity on the gel. The bulk of this intensity 
is attributable to IIBmtl; a small fraction will be due to proteins 
other than IIBmtl because the extract of cells lacking the 
plasmid also contains some protein at 16 kDa (see lane C, 
Figure 3). 
Characterization of IIBmtl. Figure 6 presents a silver-stained 
isoelectric focusing gel of purified IIBmtl at 0.4 and 0.15 mg/ 
mL in lanes B and C, respectively. It shows that the 
preparation consists of one major component. The extra bands 
in lane B below the main component probably result from 
deamidation and/or oxidation of the cysteine. An increase 
in the intensities of these bands has been observed when the 
sample was kept for longer periods in the unfrozen state. 
Gas-phase sequence determination of the first seven amino 
acid residues, Met 1 -Asp2-Pro3-Arg4-ArgS-Met6-Gln7-, con- 
firmed the expected translation start of IIBmtl from the croATG 
initiation codon. Besides the correct translation product, a 
shorter N-terminal sequence, ArgS-Met6-Gln7-Asp8-Met9- 
LyslO-Ala11-, was found. It appears to be the result of 
proteolytic cleavage between Arg4 and Arg5 in the B domain. 
Approximately 6% of the total IIBmtl was present in this form; 
it probably accounts for one of the minor bands on the 
isoelectric focusing gel (Figure 6, lane B). 
The amino acid composition of IIBmtl is presented in Table 
11. The agreement between the analysis and the composition 
expected on the basis of the DNA sequence is very good. 
Especially noteworthy is the number of phenylalanines. The 
third residue from the C-terminal end of IIBmtl is a pheny- 
lalanine; in addition, there is l other phenylalanine approx- 
imately 30 residues further toward the N-terminus. Finding 
a stoichiometry of 2 for phenylalanine in the amino acid 
composition clearly indicates that there is no significant 
proteolytic processing at the C-terminus. 
Pyruvate burst measurements on purified IIBmtl carried 
out in the presence and absence of purified IIAmtldemonstrate 
that IIBmtl can only be phosphorylated in the presence of IIAmtl. 
The data are presented in Figure 7. A background burst (0) 
was observed due to the phosphorylation of E1 and HPr. The 
same burst was observed if the reaction mixture also contained 
1.7 pM IIBmtl (A), indicating that IIBmtl could not be 
phosphorylated in the absence of IIAmtl. If 3.2 pM IIAmtl was 
added together with HPr and EI, a significant burst due to 
the phosphorylation of IIAmtl could be seen (m). Finally, 
carrying out a burst on 1.7 pM IIBmtl plus 3.2 pM IIAmtl 
resulted in a burst accounting for the sum of the IIAmtl and 
IIBmtl phosphorylation sites (+). 
For the sake of comparison with P-IIBAmtl, 31P NMR 
measurements were carried out using catalytic amounts of 
EI, HPr, and IIAmtl and 1 mM IIBmtl as described previously 
for IIBAmtl (Pas et al., 1991). Only three resonances are 
visible in the 31P NMR spectrum (Figure 8): one due to 
phosphocysteine situated at 11.7 ppm, one at 0 ppm due to 
inorganic phosphate, and one at -3 ppm arising from 
P-enolpyruvate. No P-His resonance in the vicinity of -6 to 
-7 ppm was observed. This confirms that the signal reported 
previously in the region of 11.9 ppm in IIBAmtl is due to the 
cysteine phosphorylation site on the B domain, and it indicates 
that the environments of the sites in IIBmtl and IIBAmtl are 
comparable. The slight difference in chemical shift between 
the phosphocysteine resonance in IIBmtl and IIBAmtl is probably 
due to differences in the pH of the samples. 
Measurement of the Activity of IIBmtl with II@ and IIAmtl. 
The activity of the purified B domain can be demonstrated 
by its ability to catalyze mannitol phosphorylation in the 
presence of the A and C domains. The mannitol phospho- 
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Pvruvate burst measurement of the ahosahorvlation of 
IIBmtl. Reaction mixtures of 190 p L  were prepared'con<aining 25 
mM Tris-HC1, pH 7.6, 5 mM DTT, 5 mM MgC12,0.08 pM EI, 0.7 
pM HPr, and (0) buffer, but no IIAmtl or IIBmtl, (A) 1.7 pM IIBmtl, 
(B) 3.2 pM IIAmti, or (+) 1.7 pM IIBmtl plus 3.2 pM IIAmtl. The 
reaction mixtures were incubated at 30 OC for 10 min, and then, at 
t = 0, 20 pL of 0.1 mM [14C]P-enolpyruvate was added. At the 
indicated times, 25-pL portions from the reaction mixtures were loaded 
onto Dowex columns and processed following published procedures 
(Robillard & Blaauw, 1987). 100% pyruvate is equivalent to 9.5 pM 
pyruvate. 
rylation activity of solubilized membranes expressing IIC was 
measured with increasing concentrations of IIBmtl in the 
presence of saturating concentrations of P-enolpyruvate, EI, 
HPr, and IIA"' and 33 pM mannitol. The data in Table I11 
demonstrate that IIBmtl plus IIAmtl could restore the phos- 
phorylation activity of IIC"' and that the process is saturable 
with respect to IIB"'. Although sufficient IIB"' was not 
used to measure through the KM, the dependence of the 
mannitol phosphorylation rate on the IIB"' concentration 
resulted in linear Lineweaver-Burk plots with an extrapolated 
apparent KM for P-IIB"' of approximately 200 pM and an 
apparent Vmax of 71 nmol of mtI-P min-l (mg of membrane 
protein)-' in duplicate sets of experiments. 
Measurements of the Activity of ZZBmti with EZPti-C384S. 
The simplest indication of the catalytic activity of IIB"' was 
its ability to restore activity to EIImt1-C384S in the comple- 
mentation assay. The function of IIBmtl would be to provide 
the phosphorylation site necessary to catalyze the transfer of 
the phosphoryl group from the phospho-A domain to mannitol 
bound to the C domain. We have demonstrated previously 
that the B domain of IIBA"' was able to phosphorylate 
mannitol in the same complementation assay with the EIImtl- 
C384S mutant (van Weeghel et al., 1991~). The data of the 
in vitro P-enolpyruvate-dependent complementation assay, 
as shown in Figure 4B, clearly suggest that IIBmtl is active and 
able to complement the EIImt1-C384S mutant in this mannitol 
phosphorylation reaction as well. These data, however, have 
been accumulated with membrane preparations where the 
state of EII"' is difficult to define. Stephan and Jacobson 
(1986) have provided evidence for a sensitive proteolysis site 
in the linker between the B and C domains. Consequently, 
free IICmtl may be present in the membranes, and it, rather 
than intact EIImt'-C384S, may be responsible for the com- 
plementation activity measured with IIB"'. IIB"" comple- 
mentation has been carried out with partially purified EIImt'- 
C384S to address this issue. 
EIImtl-C384S was purified by hexylagarose and Q- 
Sepharose chromatography as stated under Materials and 
Methods. Its elution characteristics are similar to those of 
native EII"' on these gels. The Q-Sepharose step is especially 
important for the present experiment because IIC"', by virtue 
of its high isoelectric point and its very hydrophobic nature, 
should not bind to this resin. As a result, a preparation of 
EIImt1-C384S can be obtained which should lack IIC"'. 
IIB"' complementation activity measurements were carried 
out exactly as stated under Materials and Methods for the 
purification of EIImt'-C384S, but in this case purified IIB"' 
(5-10 pM) replaced the I S 0  membrane vesicles containing 
EIImt'-H554A as a source of the active B domain. The 
presence of IIB"' resulted in mannitol phosphorylation rates 
with EIImt'-C384S comparable to those observed with EIImt'- 
H554A. Thesedata indicate that the complementation activity 
of isolated IIB"' with EIImtl-C384S is due to the isolated B 
domain's ability to replace the defective B domain even though 
the defective B domain is covalently attached to the A and 
C domains. 
DISCUSSION 
EII"' can be divided into three structural and functional 
domains, which can be stably expressed, and biochemically 
and kinetically studied (Stephan & Jacobson, 1986; Stephan 
et al., 1989;Grisafi et al., 1989; White &Jacobson, 1990;van 
Weeghelet al., 1991a,c;Lolkemaet al., 1990;Pasetal., 1991). 
Primary sequences of the E11 single species or EII/EIII pairs 
indicate that several of these proteins are structurally and 
evolutionarily related (Ebner & Lengeler, 1988; Saier et al., 
1988) and that they all consist of a hydrophobic transmem- 
brane domain (IIC), a hydrophilic EIII-like domain (IIA) 
containing the P-HPr phosphoryl group accepting site, and 
another hydrophilic domain (IIB) containing the second 
phosphorylation site. The E. coli cellobiose-specific and 
sorbose-specific phosphotransferase systems are the only ones 
in which IIB occurs as a separate protein (Parker & Hall, 
1990; Reizer et al., 1990; Wehmeier et al., 1992). In all other 
systems, it is found fused either to the A domain or to the C 
domain or both. We have recently expressed and characterized 
the A domain, the complete cytoplasmic BA domain, and the 
mannitol-transporting C domain (van Weeghel et al., 1991 b,c). 
The data in this paper demonstrate that IIBmtl can exist as an 
enzymatically active protein which has the capacity to restore 
the in vitro mannitol phosphorylation activity together with 
IIAmtl and IICmtl in a fashion analogous to the cellobiose- 
specific PTS. 
The concept of domain complementation arose from the 
early proposals that phosphotransferase systems which lacked 
a soluble E111 (IIA) possessed a covalently bound domain 
which took over the function of the soluble enzyme. Vogler 
et al. (1988) and Vogler and Lengeler (1988) expanded this 
concept by showing that EIInag and EIIbgl, with C-terminal 
domains highly homologous to IIAgIC, could replace IIAglc in 
EI1glC-dependent glucose phosphorylation and transport. Fur- 
thermore, addition of IIAgIC to a truncated EIInag lacking a 
functional IIAnagdomain restored the activity of the truncated 
enzyme. Their experiments provided the first evidence for 
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DTT, 4 pM EI, 5 pM HPr, 10 pM HAmt1, 20 mM P-enolpyruvate, and 1 mM IIBma. The spectrum was taken on a Varian VXR 300 at 25 
OC, using a 17-ps pulse width and a 5-s repetition rate. The data were processed with a 2-Hz line-broadening. The chemical shifts are reported 
relative to inorganic phosphate at 0 ppm. 
Table 111: IIBma Complementation Activity in Combination with 
HAmt1 and Solubilized Membranes Containing the IICma Domain" 
activity 
[IIBmtl] [nmol of mtl-P min-1 





1 1 1  25.4 
148 30.0 
(I Theassavmixtures contained 25 mM Tris-HC1. DH 7.6.5 mM MaCb 
5 mM Dl'T,b35% decyl-PEG, 24 pM HPr, 0.35 i M  EI,'30 pM IIimu; 
and the stated concentrations of IIBmU. They were incubated for 5 min 
at 30 "C. Then 10 pL of 330 pM [I4C]mtl was added. Aliquots of the 
reaction mixture were withdrawn at constant time intervals and loaded 
onto Dowexcolumns. The [ I4C]mtl-P was eluted and counted as described 
(Robillard & Blaauw, 1987). A control series of assays with 8 pM HAma 
instead of 30 pM gave nearly the same rates, indicating that the 30 pM 
IIAma used above was saturating. 
the A domain of one E11 species being able to phosphorylate 
the B domain of another enzyme. Additional support for this 
concept was provided by van Weeghel et al. (1 99 la) and more 
recently by Weng et al. (1992) by showing that two inactive 
EIImtl species with mutated phosphorylation sites, one in the 
A domain and the other in the B domain, became active when 
combined in vitro or in vivo. We can safely conclude from 
these data that the A domain of one E11 molecule is able to 
pass its phosphoryl group on to the B domain of another. 
Whether this process is transient or requires a stable dimer 
has not been settled. 
Domain complementation provided such a simple procedure 
for assaying the activity of the isolated A domain in conjunction 
with membranes containing the inactive EIImfl-H554A mutant 
that the procedure was adopted for assaying the activity of 
isolated IIBAmt' (van Weeghel et al., 1991c) and, in this report, 
for assaying isolated IIBmtl. However, since P-IIBmt' is active 
with the isolated A and C domains, it was necessary to prove 
that the complementation activity with EIImt'-C384S was due 
to replacing the defective B domain in this protein rather than 
to reaction with a C domain proteolytic fragment in the 
membrane. The data with partially purified EIImt1-C384S 
support the view that IIBmtl can replace a defective B domain 
in the intact enzyme. However, an additional test was also 
undertaken which gave a conflicting result. 
Roossien and Robillard (1984) showed that low concen- 
trations of [ 14C]NEM rapidly inactivated EIImtl with the 
concomitant incorporation of 1 mol of 14C and that this 
inactivation could be prevented by prior oxidation or phos- 
phorylation of the enzyme. Subsequently, Pas and Robillard 
(1988a) showed that C384 was the residue which was protected 
by phosphorylation and oxidation. If isolated IIBmtl could 
functionally replace the inactivated B domain as suggested 
from the complementation data with EIImt'-C384S, we 
reasoned that it should be able to restore the activity of an 
NEM-inactivated EIImtl as well. To test this, purified EIImtl 
was inactivated under essentially the same conditions used by 
Roossien and Robillard (1984), and the ability of IIBmt' to 
complement the inactive enzyme and restore its ability to 
phosphorylate mannitol was tested. Specifically, 1.5 pM 
purified EIImtl in 25 mM Tris, pH 7.6, and 5 mM DTT was 
diluted 100-fold into a buffer containing 25 mM potassium 
phosphate, pH 7.1,5 mM MgC12,0.25% d-PEG, and 0.4 mM 
NEM at 3 O O C .  TheNEMinactivationwasallowedtoproceed 
for 2 min at 30 OC. The reaction was quenched by diluting 
an aliquot 10-fold in buffer containing 25 mM Tris-HC1, pH 
7.6, 5 mM DTT, and 0.25% d-PEG and storing on ice until 
assayed. A control sample was treated in an identical manner 
except that no NEM was present. Both samples were then 
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assayed for their mannitol phosphorylation activity in the 
presence and absence of added IIBmtl. Treatment with low 
concentrations of NEM led to 80% inactivation of the mannitol 
phosphorylation activity. The presence of IIBmtl at concen- 
trations up to 38 pM was not able to restore the activity of 
the NEM-treated enzyme. 
The differences between the NEM-treated EIImtl and the 
EIImt'-C384S which could account for these discrepancies 
may have to do with an additional reaction site for NEM or 
the additional bulk introduced by the maleimide ring at the 
position of C384 which prevents the correct approach of the 
active B domain. An additional reaction site is unlikely. The 
NEM reaction was carried out under well-defined circum- 
stances where incorporation is known to occur only at C384. 
The question of additional bulk is presently under investigation 
using a series of EIImtl site-specific mutants in which C384 
has been replaced by amino acids of varying polarity, charge, 
and size. 
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